Our data demonstrated that from the immunophenotypic standing point, the analysis of tumor infiltrating CD4+ and CD8+ T-cells may represent important complementary prognosis biomarkers to be further investigated in canine mammary carcinomas. The gene discussed is CD4; the disease is neoplasm.